Musculoskeletal degeneration and peripheral neuropathies represent two of the most pervasive drivers of chronic disability and lost productivity in aging populations. To expand local clinical evidence in these critical fields, BREGO Life Sciences has introduced the Powering Mobility: RISE Program, channeling resources directly into grassroots research across Malaysian clinics and hospitals.
Despite high clinical caseloads of degenerative osteoarthritis and nerve-related disorders in Malaysian health facilities, localized real-world evidence and published case registries often lag behind international benchmarks. Clinical observations made by frontline doctors frequently go unpublished because medical officers lack dedicated pathways to navigate study approvals, statistical analyses and scientific peer review.
The RISE initiative targets this specific gap by focusing its entire inaugural funding cycle on Joint Health and Nerve Health. Eligible healthcare practitioners are invited to submit abstracts covering original observational trials, clinical audits or detailed case reports. Independent scientific panels will review all submissions, prioritizing studies demonstrating practical utility, rigorous methodology and immediate relevance to patient outcomes.
Up to 40 submissions split equally between joint and nerve disciplines will qualify for dedicated development opportunities during the 2026/2027 cycle, which accepts proposals through January 2027. Top candidates will receive tailored scientific support to guide their work toward presentation and potential journal publication.
Speaking on the community impact, BREGO Life Sciences Managing Director Dr. Danny Wong highlighted that robust local clinical data is the cornerstone of better therapeutic standards. Generating homegrown evidence ensures that diagnostic criteria, preventive strategies and treatment algorithms are fine-tuned to the genetics, lifestyles and healthcare delivery realities of Malaysian patients.
By encouraging clinician-led inquiry into how joints and nerves degrade and recover, the RISE program serves a dual purpose: it empowers doctors to contribute to scientific literature while accelerating insights that directly help patients maintain mobility, independence and long-term functional well-being.
